Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities
FDA Law
SEPTEMBER 13, 2021
Medicare negotiation authority; encourage biosimilars and generic drug utilization). Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs. The Plan supports legislative action to control total drug costs and patient out-of-pocket (“OOP”) costs for Medicare Part D beneficiaries.
98 
Let's personalize your content